Search Results 501-510 of 17116 for Lecithin

  1. Niacin overdose: What are the symptoms? - Mayo Clinic

    Severe skin flushing combined with dizziness. Rapid heartbeat. Itching. Nausea and vomiting. Abdominal pain. Diarrhea. Gout. Rash. If you think you may have ...

  2. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    About this study. To study the safety and side effects of Ofatumumab in the treatment of chronic graft-versus-host disease (GvHD).

  3. Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility - Mayo Clinic

    This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against ...

  4. A Study to Evaluate the Effectiveness and Safety of an Amikacin Liposome Inhalation Suspension-based Regimen in Adults with Nontuberculous Mycobacterial Lung Infection - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of ALIS + azithromycin (AZI) + ethambutol (ETH) compared to the empty liposome control (ELC) + AZI + ...

  5. Laboratories - Mayo Clinic Research

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  6. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

    A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of ...

  7. Ertugliflozin and sitagliptin (oral route) - Side effects & dosage - Mayo Clinic

    Ertugliflozin and sitagliptin combination is used with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. Ertugliflozin works ...

  8. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    The purpose of this study to assess pharmacodynamic (PD) changes in tumor tissue. Participation eligibility. Participant eligibility includes age, gender, type ...

  9. IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome - Mayo Clinic

    About this study. The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate ...

  10. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial - Mayo Clinic

    A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...